[2] Neoadjuvant intravesical chemotherapy to treat extended large non-muscle-invasive bladder cancer
Objective: To report our experience with the use of neoadjuvant intravesical chemotherapy in the treatment of large exophytic bladder tumours. About 75% of bladder cancers are superficial at diagnosis. Sometimes, symptoms are mild or absent, and the tumour can grow unnoticed into a large intra-lumin...
Saved in:
Main Authors: | Marco Raber, Ismail Hassan, Nashaat Hendawi, Noor Buchholz |
---|---|
Format: | article |
Language: | EN |
Published: |
Taylor & Francis Group
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/0ac3360b28ca4a00b728104860f95059 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases
by: Marco Raber, et al.
Published: (2018) -
[7] Efficacy, complications and tolerability of repeated intravesical onabotulinumtoxinA injections in interstitial cystitis/bladder pain syndrome
by: Riyad Al Mousa, et al.
Published: (2018) -
[81] Correlation between intravesical prostatic protrusion and the failure of medical treatment
by: Redouane Rabii, et al.
Published: (2018) -
Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
by: Mi Ah Han, et al.
Published: (2021) -
[53] Neutrophil-to-lymphocyte ratio in non-muscle-invasive bladder cancer
by: Anés Sempere, et al.
Published: (2018)